Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells
João T. Barata(Instituto Gulbenkian de Ciência), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center)
Cited by 274
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.1k
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
|Frontiers in Immunology|2016|596
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
|Journal of Clinical Investigation|2008|441
PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2
|Molecular and Cellular Biology|2013|186